This report from SABCS 2007 provides the latest data on the role of endocrine therapy for patients with early stage breast cancer. Medscape Hematology-Oncology
In this SABCS 2007 summary, Dr. Kathy D. Miller discusses results of a number of studies that may influence treatment decisions for women with metastatic breast cancer.
In this report from SABCS 2007, Drs. Lawrence Shulman and Erica Mayer review the latest research data on the management of treatment-resistant metastatic breast cancer.
Reinduction of endocrine sensitivity can follow chemotherapy for androgen-independent prostate cancer (AIPC), according to a report in the January 8th British Journal of Cancer. Reuters Health Information
The majority of male patients treated for advanced Hodgkin lymphoma (HL) with the BEACOPP chemotherapy protocol become infertile as a result, though most already have impaired semen quality before treatment, according to the most comprehensive analysis of such patients to date. Reuters Health Information
In this Expert Interview from SABCS 2007, Dr. Linda Vahdat talks about new drugs and strategies that represent important trends in breast cancer treatment. Medscape Hematology-Oncology
Contrary to what has been hypothesized, high circulating androgen levels are not associated with an increased risk for ovarian cancer, according to findings published in the January issue of the American Journal of Epidemiology. Reuters Health Information
Induction of the cytoprotective gene heme oxygenase-1 (HO-1) underlies the resistance of acute myelogenous leukemia (AML) cells to TNF-induced apoptosis, according to a report issued online January 17th by the journal Blood. Reuters Health Information
Adjuvant external-beam radiation therapy (EBRT) improves survival in patients with operable, lymph node-negative pancreatic cancer, according to a report in the January 1st issue of Cancer. Reuters Health Information
